Completed OBSERVATIONAL NCT04695366

The Potential of Patient-reported Outcome Measures in Detection of Relapse in Diffuse Large B-cell Lymphoma

The Potential of Patient-reported Outcome Measures in Detection of Relapse in Diffuse Large B-cell Lymphoma - a Prospective Cohort Study

Sponsor: Herlev Hospital

Conditions Diffuse Large B Cell Lymphoma Patient Reported Outcome

Interventions No intervention

Updated 6 times since 2021 Last updated: Feb 27, 2024 Started: Feb 10, 2021 Primary completion: Apr 30, 2023 Completion: Apr 30, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Diffuse Large B Cell Lymphoma and Patient Reported Outcome and is currently completed. Herlev Hospital leads this study, which shows 6 recorded versions since 2021 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Mar 2024 — Jul 2024 [monthly]

Completed

Status: Recruiting → Completed
Apr 2022 — Mar 2024 [monthly]

Recruiting
Mar 2021 — Apr 2022 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Feb 2021 — Mar 2021 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Herlev Hospital

Data source: Herlev Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Copenhagen, Denmark